HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
G Viale Selected Research
G Viale Research Topics
Disease
70
Breast Neoplasms (Breast Cancer)
12/2022 - 01/2000
52
Neoplasms (Cancer)
12/2022 - 01/2000
20
Neoplasm Metastasis (Metastasis)
12/2022 - 01/2001
9
Triple Negative Breast Neoplasms
01/2022 - 01/2011
9
Carcinoma (Carcinomatosis)
09/2009 - 01/2000
4
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2017 - 12/2005
3
Carcinogenesis
12/2022 - 06/2000
3
Adenocarcinoma
04/2007 - 03/2001
3
Lymphatic Metastasis
03/2007 - 06/2000
2
Pathologic Complete Response
01/2022 - 12/2016
2
Residual Neoplasm
01/2017 - 02/2015
2
Hemangiosarcoma (Angiosarcoma)
05/2015 - 07/2014
2
Ductal Carcinoma
10/2013 - 08/2001
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2009 - 02/2003
2
Adenosquamous Carcinoma
02/2003 - 03/2001
2
Disease Progression
02/2003 - 05/2001
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2003 - 03/2001
2
Lymphoma (Lymphomas)
11/2001 - 08/2000
2
Epstein-Barr Virus Infections
10/2001 - 06/2000
1
Brain Stem Neoplasms (Brain Stem Tumor)
06/2021
1
Cardiotoxicity
01/2018
1
Heart Failure
01/2018
1
Insulin Resistance
11/2013
1
Necrosis
04/2013
1
Atrial Fibrillation
08/2012
1
Acute Promyelocytic Leukemia
05/2011
1
Testicular Neoplasms (Testicular Cancer)
01/2011
1
Infections
09/2009
Drug/Important Bio-Agent (IBA)
17
Estrogen Receptors
IBA
10/2020 - 08/2000
13
Biological Products
IBA
02/2015 - 05/2001
13
Progesterone Receptors (Progesterone Receptor)
IBA
03/2013 - 01/2000
10
Phenobarbital (Luminal)
FDA Link
09/2020 - 10/2010
9
Hormones (Hormone)
IBA
12/2022 - 08/2000
9
Tamoxifen
FDA Link
Generic
12/2015 - 05/2007
7
Biomarkers (Surrogate Marker)
IBA
12/2022 - 11/2004
7
human ERBB2 protein
IBA
10/2020 - 04/2008
6
Methotrexate (Mexate)
FDA Link
Generic
12/2022 - 01/2002
6
Letrozole (Femara)
FDA Link
Generic
10/2021 - 05/2007
5
Proteins (Proteins, Gene)
FDA Link
05/2015 - 06/2000
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2011 - 01/2002
5
Fluorouracil (Carac)
FDA Link
Generic
10/2011 - 11/2001
4
Trastuzumab (Herceptin)
FDA Link
01/2018 - 12/2007
4
Eosine Yellowish-(YS) (Eosin)
IBA
02/2015 - 06/2001
4
Hematoxylin (Haematoxylon)
IBA
02/2015 - 06/2001
4
Messenger RNA (mRNA)
IBA
10/2007 - 06/2000
4
Monoclonal Antibodies
IBA
03/2001 - 01/2000
3
Estrogens (Estrogen)
FDA Link
10/2021 - 01/2000
3
Anthracyclines
IBA
01/2018 - 11/2001
3
Aromatase Inhibitors
IBA
10/2011 - 05/2007
3
Vinorelbine (Navelbine)
FDA Link
Generic
11/2008 - 11/2001
3
Indicators and Reagents (Reagents)
IBA
10/2007 - 06/2000
2
Ligands
IBA
10/2018 - 06/2000
2
taxane
IBA
01/2018 - 11/2008
2
Insulin-Like Growth Factor I (IGF-1)
IBA
03/2014 - 06/2000
2
Docetaxel (Taxotere)
FDA Link
05/2013 - 11/2008
2
Goserelin (Zoladex)
FDA Link
10/2011 - 02/2010
2
fascin
IBA
04/2007 - 02/2003
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2006 - 01/2002
2
Cisplatin (Platino)
FDA Link
Generic
10/2003 - 11/2001
2
Keratins (Keratin)
IBA
12/2001 - 06/2001
2
Protein Isoforms (Isoforms)
IBA
08/2001 - 01/2000
2
Antibodies
IBA
08/2001 - 06/2000
2
Coloring Agents (Dyes)
IBA
08/2001 - 10/2000
1
Carbon
IBA
12/2022
1
Antimetabolites
IBA
12/2022
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
12/2022
1
Serine (L-Serine)
FDA Link
12/2022
1
Folic Acid (Vitamin M)
FDA Link
Generic
12/2022
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
12/2022
1
atezolizumab
IBA
01/2022
1
pertuzumab
IBA
01/2018
1
Diphosphonates (Bisphosphonates)
IBA
01/2017
1
ErbB Receptors (EGF Receptor)
IBA
04/2015
1
Sex Hormone-Binding Globulin
IBA
03/2014
1
Pharmaceutical Preparations
IBA
03/2014
1
C-Reactive Protein
IBA
03/2014
1
Metformin (Glucophage)
FDA Link
Generic
11/2013
1
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
11/2013
1
Progesterone
FDA Link
Generic
10/2013
1
Androgen Receptors (Androgen Receptor)
IBA
09/2013
1
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2013
1
Quinidine (Chinidin)
FDA Link
Generic
08/2012
1
Retinoic Acid Receptor alpha
IBA
05/2011
1
Promyelocytic Leukemia Protein
IBA
05/2011
1
Vaccines
IBA
01/2011
1
Antigens
IBA
01/2011
Therapy/Procedure
26
Drug Therapy (Chemotherapy)
12/2022 - 08/2000
25
Therapeutics
12/2022 - 12/2003
10
Radiotherapy
12/2017 - 08/2006
8
Neoadjuvant Therapy
01/2022 - 01/2007
5
Adjuvant Chemotherapy
06/2021 - 11/2008
2
Segmental Mastectomy (Lumpectomy)
12/2017 - 10/2003
2
Mastectomy (Mammectomy)
09/2009 - 12/2005
2
Combination Drug Therapy (Combination Chemotherapy)
08/2008 - 12/2006
2
Lymph Node Excision (Lymph Node Dissection)
08/2006 - 09/2001
2
ViFuP protocol
10/2003 - 11/2001
1
Maintenance Chemotherapy
12/2022
1
Immunotherapy
01/2017
1
Conservative Treatment
04/2011
1
Transjugular Intrahepatic Portasystemic Shunt
01/2011